A Progressively Disassembled DNA Repair Inhibitors Nanosystem for the Treatment of BRCA Wild-Type Triple-Negative Breast Cancer

BACKGROUND: Olaparib, a poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor has demonstrated promising efficacy in patients with triple-negative breast cancer (TNBC) carrying breast cancer gene (BRCA) mutations. However, its impact on BRCA wild-type (BRCAwt) TNBC is limited. Hence, it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Weimin, Wang, Jinghao, Ma, Xiaocong, Shao, Ni, Ye, Kunlin, Zhang, Dong, Shi, Changzheng, Luo, Liangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612513/
https://www.ncbi.nlm.nih.gov/pubmed/37901361
http://dx.doi.org/10.2147/IJN.S426639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612513/
https://www.ncbi.nlm.nih.gov/pubmed/37901361
http://dx.doi.org/10.2147/IJN.S426639

Ejemplares similares